PRKAA2 and leukemia: Strikingly, leukemia clearance continued to be equivalent between recipients of AMPK-dKO and fl/fl cells with as few as 0.1 × 106 donor T cells/recipient (n = 6–8 mice/group; Supplemental Figure 4, A–C).